Stem Cell Ophthalmology Treatment Study Releases Data on ClinicalTrials.gov Website

MD Stem Cells publishing positive, statistically significant results on treatments in SCOTS. - February 13, 2018 - MD Stem Cells

MD Stem Cells Announces New Spinal Cord Stem Cell Treatment Combined with Exoskeleton and Virtual Reality

MD Stem Cells coordinates latest technologies to advance stem cell treatment of paraplegia. - February 12, 2018 - MD Stem Cells

Apostle Inc Appoints David B. Goldstein, PhD at Columbia University to Scientific Advisory Board

Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc

Oxford Optronix Ltd. and Scintica Instrumentation Inc. Proudly Announce Agreement on Official Product Distribution for North America

With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix. The Scintica team consists of... - February 07, 2018 - Scintica Instrumentation

Proteos Moves Toward Employee Ownership

Proteos, Inc. announced on Monday January 29, 2018 that the company would begin the process of restructuring and transitioning to a majority employee-owned corporation. Since its founding in 2003, by Clark W. Smith, Ph.D. and Robert L. Heinrikson, Ph.D., Proteos has been committed to both customer... - February 03, 2018 - Proteos

Improving the Health of South Asians Across the Globe

Many people are looking at their parents, grandparents and families and seeing cancer, diabetes, heart disease and rare diseases, all of which can have a genetic component. South Asians have twice the rate of genetic disease compared to the rest of the world, yet there is far less data, less than 1% of the available data. So people don’t know what they are carrying, and they want better diagnosis and treatments for their family members. #MaptheGap will start to address this. - February 02, 2018 - Map the Gap

Phelix Therapeutics, LLC Awarded Phase I SBIR Grant from NIH to Develop Calpain Therapeutics for Idiopathic Pulmonary Fibrosis

Phelix Therapeutics, LLC is pleased to announce it has received a $201,665 grant from the National Institutes of Health (NIH). This Small Business Innovation Research (SBIR) funding will support Phelix’s continued research of Calpain therapeutics to inhibit myofibroblast generation in... - January 31, 2018 - Phelix Therapeutics, LLC

InBody Will Provide Free Body Composition Tests to Border Security Expo Attendees, January 31 to February 1

Visitors will also receive a free consultation at the body composition analyzer’s booth (#409) in the Henry B. Gonzalez Convention Center in San Antonio, TX. - January 31, 2018 - InBody

NanoHybrids Launches Revolutionary Contrast Agent to Measure EPR Effect at 2018 SPIE BiOS Expo

NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids

Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit

Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit

Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.

Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration

Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates

InBody Will Provide Free Body Composition Tests at ASPEN 2018 Nutrition Science & Practice Conference in Las Vegas, Nevada

Attendees will also receive a free consultation at InBody’s booth (#200) in Caesar’s Palace from January 23rd to January 24th. - January 24, 2018 - InBody

What’s Better Than Winning a Mobile Website Design Award? Winning 2 Mobile Website Design Awards!

What’s Better Than Winning a Mobile Website Design Award? Winning 2 Mobile Website Design Awards!

Arteric.com named Best Advertising Mobile Website and Best Interactive Services Mobile Website. - January 17, 2018 - Arteric

European Commission Approves Endoceutics’ Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

European Commission Approves Endoceutics’ Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human... - January 15, 2018 - Endoceutics

DrugCendR Inc. to Present Phase I Plans on 2 Occasions During the JP Morgan Healthcare Conference in San Francisco Next Week

As DrugCendR is now preparing to transition from a preclinical to a clinical-stage company, the company will present details on their Phase I–ready lead compound CEND-1 – a highly innovative molecular mimicry agent that is able to activate a drug transport mechanism specifically in solid tumors. To date, there are more than 100 studies using DrugCendR’s proprietary technology, providing an unprecedented amount of preclinical validation / proof-of-concept. - January 04, 2018 - DrugCendR

SARI Announced It Has Entered Into an Agreement to Acquire the 90% Interests in NMS Group

SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group

NINDS Awards $150,000 Grant to NuvOx Pharma for Development of Field-Ready Syringe for Oxygen Delivery Drug

NuvOx Pharma, a clinical stage biotechnology company, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS). This grant will fund development of a novel syringe sonication device that... - December 30, 2017 - NuvOx Pharma

SCOTS Eye Stem Cell Study Reports Vision Recovery in Optic Nerve Stroke (NAION); Other Blindness

Stem Cell Ophthalmology Treatment Study in Florida makes progress treating “untreatable” optic nerve and retinal conditions with publication of positive outcomes. - December 29, 2017 - MD Stem Cells

AdvantaPure(R) Introduces Sterile, Single-Use, Molded Filling Assemblies for Aseptic Fill and Finish Applications

Single-Use filling assemblies for fill and finish applications in biopharmaceutical and pharmaceutical processing are now available from AdvantaPure. They feature molded connections for seamless fluid flow. Supplied sterilized and ready to install, the assemblies are manufactured with tubing, bags, filters, sterile connectors, filling needles and other accessories specified by the customer. Two tubing materials are offered. - December 21, 2017 - AdvantaPure

cliexa® Partners with Preventative Technology Solutions on Risk Assessment Solutions; New Product Will Help Physicians Address Behavioral Health Risks in Adolescents

cliexa® Partners with Preventative Technology Solutions on Risk Assessment Solutions; New Product Will Help Physicians Address Behavioral Health Risks in Adolescents

cliexa, Inc., developer of a mobile platform for chronic disease management, announces today a collaboration with Preventative Technology Solutions, Inc., (PTSI), provider of medical assessment applications and mHealth prevention services for adolescents and young adults. cliexa has licensed PTSI... - December 19, 2017 - cliexa

Targeted Hyperthermia Treatment Accepted for Full Characterization at the Frederick National Laboratory for Cancer Research

Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids

NanoHybrids Inc. Awarded NIH Grant to Advance Nanoparticle Enabled Photodynamic Therapy for Oral Cancer

NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids

BioStat Solutions, Inc. (BSSI) Announces New Director of Clinical Operations – Eloi Kpamegan, Ph.D.

BioStat Solutions, Inc. today announced that Eloi Kpamegan, Ph.D. has accepted the position of Director, Clinical Operations. - December 14, 2017 - BioStat Solutions, Inc.

Qualitative Identification of Synthetic Cannabinoids Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF/MS)

A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent... - December 14, 2017 - Cayman Chemical Company

GeneFluidics Announces CE-IVD Marking of UtiMax™ Uropathogen Identification (ID) and Antimicrobial Susceptibility Testing (AST)

GeneFluidics Announces CE-IVD Marking of UtiMax™ Uropathogen Identification (ID) and Antimicrobial Susceptibility Testing (AST)

GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.

VistaVu Solutions Acquires BPBD and Their SAP Business ByDesign Company

Acquisition continues to grow VistaVu Solutions’ Commitment to SAP Business ByDesign business segment. - December 07, 2017 - BPBD LLC

Making Artificial Intelligence Practical for Healthcare Marketers

Making Artificial Intelligence Practical for Healthcare Marketers

Arteric Explains How to Uncover Hidden Marketing Insights. - December 06, 2017 - Arteric

RegenLab Issued New US Patent for Platelet Rich Plasma Kits

RegenLab Issued New US Patent for Platelet Rich Plasma Kits

RegenLab is attempting to enforce its patent rights against Estar Technologies Ltd., manufacturer of the Eclipse PRP product, Eclipse Aesthetics LLC, a US distributor, as well as their customers. - December 05, 2017 - RegenLab

No Insight Left Behind. Guiding Healthcare Marketers to Wise Decisions About Artificial Intelligence.

No Insight Left Behind. Guiding Healthcare Marketers to Wise Decisions About Artificial Intelligence.

Arteric Shares Its Practical Approach to Applying AI to Uncover Marketing Insights. - November 27, 2017 - Arteric

Creative BioMart to Expand Its Protein Glycosylation Labeling Service Capacity to Meet Rising Demands

Creative BioMart, a global leader in the supply of high quality protein products and efficient protein manufacturing techniques, today announced a major expansion of its Protein Glycosylation Labeling Service capacities as a response to rising customer needs and market demands for characterizing... - November 26, 2017 - Creative Biomart

Arteric Pushes Boundaries with Its New Corporate Website, Arteric.com

Healthcare Digital Marketing Agency Shares Strategic and Tactical Insights in a Future-Ready Experience - November 21, 2017 - Arteric

Stool Bank in Asia Welcomes New Scientist

Stool Bank in Asia Welcomes New Scientist

The Asia Microbiota Bank, the first stool bank in Hong Kong, expands the team by adding a new scientist to help lead research efforts on bacteria clusters unique to the Asian population. The scientific team uses next generation sequencing and strain level analysis to optimize Fecal Microbiota Transplantation (FMT) treatment outcomes in Asia. "We hope that the deep FMT data we are collecting from around Asia will help uncover key strains that influence intestinal health."-Co-Founder, Jon Chan - November 16, 2017 - Asia Microbiota Bank

New Intelligence Tool Helps Researchers Cope with Immuno-Oncology Boom

Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to pharma scientists and strategists in the booming immuno-oncology combination field of study. IO Combination Trials... - November 16, 2017 - Beacon Intelligence

Cellenkos Inc. Enters Regulatory T-Cell Platform Research Collaboration with MD Anderson

Cellenkos Inc. Enters Regulatory T-Cell Platform Research Collaboration with MD Anderson

Cellenkos Inc. has announced a multi-year collaboration with The University of Texas MD Anderson Cancer Center focused on development of cord blood regulatory T cell (CB TREG) therapeutics for treatment of autoimmune disease and inflammatory disorders. As part of this collaboration, Cellenkos Inc. - November 15, 2017 - Cellenkos Inc.

Virun® NutraBIOsciences® Receives Certification for Production of Organic Products While Launching Natural Algal DHA MCT Multi-serving Smoothies

Virun® NutraBIOsciences® Receives Certification for Production of Organic Products While Launching Natural Algal DHA MCT Multi-serving Smoothies

Virun® NutraBIOsciences® Prepares to Enter the Finished Product Market with Novel Flavors and Celebrates State Organic Certification. - November 14, 2017 - VIRUN

The European Medicines Agency Accepts Marketing Authorisation Application for Intrarosa for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Endoceutics Inc., a private Quebec City based biopharma company, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product IntrarosaTM, intended for the treatment of... - November 13, 2017 - Endoceutics

A Practical Discussion About AI and Machine Learning in Healthcare Digital Marketing

A Practical Discussion About AI and Machine Learning in Healthcare Digital Marketing

Arteric’s President Prepares Healthcare Marketers to Transform Digital Disruption Into Competitive Advantage. - November 08, 2017 - Arteric

Virun® NutraBioSciences®, and Algarithm Ingredients Inc. to Lead Plant-Based Panel at SXSW Conference in 2018

Virun® NutraBioSciences®, and Algarithm Ingredients Inc. to Lead Plant-Based Panel at SXSW Conference in 2018

Growing market demand for plant-based DHA omega-3 ingredients intersects with innovative food technology. - November 03, 2017 - VIRUN

BPBD, a Leading SAP Business ByDesign Provider, Expands Global Reach with German-Based all4cloud Partnership

BPBD adds all4cloud’s eam4cloud and scan4cloud to its new product offerings. - November 02, 2017 - BPBD LLC

MBF Therapeutics Inc. to Present at Philadelphia PACT Investor Conference

MBF Therapeutics, Inc., a clinical stage animal health company developing checkpoint inhibitor vaccines for cancer and infectious diseases, today announced that Thomas Tillett, Chief Executive Officer, will present at the PACT Capital Conference in Philadelphia, PA on Thursday, November 2, 2017 at... - November 01, 2017 - MBF Therapeutics Inc

Artificial Intelligence Accelerates Marketing: Biopharma and Medical Device eMarketing Summit

Artificial Intelligence Accelerates Marketing: Biopharma and Medical Device eMarketing Summit

Digital Marketing Thought Leader Prepares Healthcare Marketers for the Next Digital Disruption - October 30, 2017 - Arteric

Clinerion Expands the Global Coverage of Its Services in the Americas, Adding 60 Million Patients in North America via Partnership with Provisio Inc.

Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities. - October 30, 2017 - Clinerion

NASA’s James Webb Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators

NASA’s James Webb Space Telescope, the replacement to the Hubble Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators in Johnson Space Center's Vaccum Chamber A being tested. - October 28, 2017 - Minus K Technology Inc.

Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys

Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys

Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB

Prosidyan Announces FDA Clearance and Commercial Launch of Its FIBERGRAFT BG MATRIX for Poster-Lateral Spinal Fusion

NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today FDA 510(k) clearance and full commercial launch of FIBERGRAFT BG Matrix – Bone Graft Substitute for Postero-lateral Spinal Fusion. FIBERGRAFT BG Matrix is the third... - October 26, 2017 - Prosidyan, Inc.

Batavia Biosciences Expands Its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand

Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand. - October 18, 2017 - Batavia Biosciences

Qrons Inc. Announces Launch of New Website Website Offers Visitors Insight Into the Company's Innovative Multi-Disciplinary Approach to Traumatic Brain Injuries

Qrons Inc. Announces Launch of New Website Website Offers Visitors Insight Into the Company's Innovative Multi-Disciplinary Approach to Traumatic Brain Injuries

Qrons Inc. (OTCPK: QRON) ("Qrons " or the "Company"), a preclinical biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries, announced today the launch of its fully featured website. The website... - October 10, 2017 - Qrons Inc.

G&L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs

G&L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs

Global provider of Clinical & Regulatory Affairs consultancy services continues to attract top talent. - October 09, 2017 - G&L Scientific Inc

Digital Pharma East and Arteric Have Partnered to Lead Healthcare Marketing’s Digital Transformation

Digital Marketing Agency Continues Support of Major Healthcare Conference. - October 04, 2017 - Arteric

BPBD, a Leading SAP Business ByDesign Partner, Introduces New Pharmaceutical Manufacturing Add-On Solution for Business ByDesign

BPBD’s New Pharma Manufacturing Solution Add-On Enables Cloud-Based ERP Solution for Compliance Certification with FDA CFR 21 Part 11 and EU Annex 11 - October 04, 2017 - BPBD LLC

Press Releases 301 - 350 of 2,966